10x Genomics (TXG) Acquisitions (2021 - 2022)

10x Genomics' (TXG) quarterly Acquisitions came in at $2.5 million in Q4 2022, up 66.67% quarter-over-quarter from $1.5 million in Q3 2022.

10x Genomics (TXG) Acquisitions (2021 - 2022) Analysis & Trends

10x Genomics has disclosed Acquisitions across 2 years of filings, most recently posting $2.5 million for Q4 2022.

Acquisitions for Q4 2022 came in at $2.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $4.0 million (changed 0.0% YoY), and the FY2022 annual result was $4.0 million, down 26.62% from the prior year.
Acquisitions came in at $2.5 million for Q4 2022 at 10x Genomics, up from $1.5 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $5.5 million in Q1 2021 to a low of $1.5 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	75.48 Mn
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	42.20 Mn
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	-
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	-
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	2.04 Mn
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	-
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	-
10	Teladoc Health	1.45 Bn	696.57 Mn	562.57 Mn	-

Download Data